Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 2740826, 6 pages
http://dx.doi.org/10.1155/2016/2740826
Research Article

Diagnostic Utility of ANG in Coronary Heart Disease Complicating Chronic Heart Failure: A Cross-Sectional Study

Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Shanghai Medical College of Fudan University, Shanghai 200032, China

Received 28 July 2016; Revised 30 September 2016; Accepted 12 October 2016

Academic Editor: Michele Malaguarnera

Copyright © 2016 Peng Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. W. Yancy, M. Jessup, B. Bozkurt et al., “2013 Accf/aha guideline for the management of heart failure,” Journal of the American College of Cardiology, vol. 62, no. 16, pp. e147–e239, 2013. View at Publisher · View at Google Scholar
  2. D. Mozaffarian, E. J. Benjamin, A. S. Go et al., “Heart disease and stroke statistics—2015 update: a report from the American Heart Association,” Circulation, vol. 131, no. 4, pp. e29–e322, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. R. K. Riezebos, E. Ronner, B. A. de Boer, E. H. Slaats, J. G. P. Tijssen, and G.-J. Laarman, “Dynamics in N-terminal pro-brain natriuretic peptide concentration in patients with non-ST-elevation acute coronary syndrome,” American Heart Journal, vol. 150, no. 6, pp. 1255–1259, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Tello-Montoliu, F. Marín, J. Patel et al., “Plasma angiogenin levels in acute coronary syndromes: implications for prognosis,” European Heart Journal, vol. 28, no. 24, pp. 3006–3011, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Krecki, M. Krzemińska-Pakuła, J. Drozdz et al., “Relationship of serum angiogenin, adiponectin and resistin levels with biochemical risk factors and the angiographic severity of three-vessel coronary disease,” Cardiology Journal, vol. 17, no. 6, pp. 599–606, 2010. View at Google Scholar · View at Scopus
  6. J. V. Patel, M. Sosin, A. Gunarathne et al., “Elevated angiogenin levels in chronic heart failure,” Annals of Medicine, vol. 40, no. 6, pp. 474–479, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Jiang, L. Zhang, Y. Yu et al., “A pilot study of angiogenin in heart failure with preserved ejection fraction: a novel potential biomarker for diagnosis and prognosis?” Journal of Cellular and Molecular Medicine, vol. 18, no. 11, pp. 2189–2197, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Eleuteri, A. Di Stefano, F. Tarro Genta et al., “Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure,” European Journal of Cardiovascular Prevention & Rehabilitation, vol. 18, no. 4, pp. 607–614, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Frantz, C. Monaco, and F. Arslan, “Danger signals in cardiovascular disease,” Mediators of Inflammation, vol. 2014, Article ID 395278, 2 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Voltan, G. Zauli, P. Rizzo et al., “In vitro endothelial cell proliferation assay reveals distinct levels of proangiogenic cytokines characterizing sera of healthy subjects and of patients with heart failure,” Mediators of Inflammation, vol. 2014, Article ID 257081, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Thygesen, J. S. Alpert, A. S. Jaffe et al., “Third universal definition of myocardial infarction,” Journal of the American College of Cardiology, vol. 60, no. 16, pp. 1581–1598, 2012. View at Google Scholar
  12. L. Desta, T. Jernberg, I. Lofman et al., “Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The swedeheart registry (swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies): a study of 199,851 patients admitted with index acute myocardial infarctions, 1996 to 2008,” JACC Heart Fail, vol. 3, no. 3, pp. 234–242, 2015. View at Google Scholar
  13. M. Bay, V. Kirk, J. Parner et al., “NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function,” Heart, vol. 89, no. 2, pp. 150–154, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Tello-Montoliu, J. V. Patel, and G. Y. H. Lip, “Angiogenin: a review of the pathophysiology and potential clinical applications,” Journal of Thrombosis and Haemostasis, vol. 4, no. 9, pp. 1864–1874, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Kishimoto, S. Liu, T. Tsuji, K. A. Olson, and G.-F. Hu, “Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis,” Oncogene, vol. 24, no. 3, pp. 445–456, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. L.-X. Qin and Z.-Y. Tang, “The prognostic molecular markers in hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 8, no. 3, pp. 385–392, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. K. A. Oikonomou, A. N. Kapsoritakis, A. I. Kapsoritaki et al., “Angiogenin, angiopoietin-1, angiopoietin-2, and endostatin serum levels in inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 17, no. 4, pp. 963–970, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Li and G.-F. Hu, “Emerging role of angiogenin in stress response and cell survival under adverse conditions,” Journal of Cellular Physiology, vol. 227, no. 7, pp. 2822–2826, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Eleuteri, A. Di Stefano, F. T. Genta et al., “Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 18, no. 4, pp. 607–614, 2011. View at Publisher · View at Google Scholar · View at Scopus